Home › Funds › AQR Capital Management › PCVX
AQR Capital Management position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)34.56K sh
Reported value held$2.01M
Portfolio Weight0.00%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 9.33K | $224.00K | New |
| Q4 2022 | 11.44K | $548.40K | Add |
| Q1 2023 | 12.74K | $477.61K | Add |
| Q2 2023 | 14.37K | $717.64K | Add |
| Q3 2023 | 12.50K | $637.25K | Reduce |
| Q4 2023 | 12.10K | $759.88K | Reduce |
| Q1 2024 | 10.53K | $719.44K | Reduce |
| Q2 2024 | 10.86K | $820.04K | Add |
| Q3 2024 | 11.11K | $1.27M | Add |
| Q4 2024 | 24.52K | $2.01M | Add |
| Q1 2025 | 6.57K | $248.16K | Reduce |
| Q2 2025 | 6.38K | $207.45K | Reduce |
| Q4 2025 | 14.76K | $681.12K | New |
| Q1 2026 | 25.46K | $1.48M | Add |
| Q2 2026 | 34.56K | $2.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026
- JPMorgan Chase & Co 1.23M sh · $71.19M · Q2 2026